Opportunistic amoebae: challenges in prophylaxis and treatment.
about
Antiparasitic therapyIn-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleriPhotosensitized inactivation of Acanthamoeba palestinensis in the cystic stage.Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of AcanthamoebaEnucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis.Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.Survey of Naegleria fowleri in geothermal recreational waters of Guadeloupe (French West Indies).Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid.Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens.Acanthamoeba species in Swimming Pools of Cairo, Egypt.Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis.Transmission of Balamuthia mandrillaris through solid organ transplantation: utility of organ recipient serology to guide clinical management.Fatal Balamuthia amebic encephalitis in a healthy child: a case report with review of survival cases.Free-living amoebae and their intracellular pathogenic microorganisms: risks for water quality.In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review.Disseminated Acanthamoeba Infection Presenting With Cutaneous Lesions in an Immunocompromised Patient: A Case Report, Review of Histomorphologic Findings, and Potential Diagnostic Pitfalls.Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.The Development of Drugs against Acanthamoeba Infections.Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference.Granulomatous amebic encephalitis in a child with acute lymphoblastic leukemia successfully treated with multimodal antimicrobial therapy and hyperbaric oxygen.Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.Apoptosis of Acanthamoeba castellanii Trophozoites Induced by Oleic Acid.Surveillance and Molecular Identification of Acanthamoeba and Naegleria Species in Two Swimming Pools in Alexandria University, Egypt.Sensitivity of Enzymatic Toxins from Corneal Isolate of Acanthamoeba Protozoan to Physicochemical Parameters.Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.Detection and quantification of human adenovirus genomes in Acanthamoeba isolated from swimming pools.Management of granulomatous amebic encephalitis: Laboratory diagnosis and treatment.Balamuthia mandrillaris: Morphology, biology, and virulence.Diagnosis of first case of Balamuthia amoebic encephalitis in Portugal by immunofluorescence and PCR.Abietane diterpenoids from Salvia sclarea transformed roots as growth inhibitors of pathogenic Acanthamoeba spp.First Report of Hartmannella keratitis in a Cosmetic Soft Contact Lens Wearer in IranChloroquine has a cytotoxic effect on Acanthamoeba encystation through modulation of autophagySuccessful treatment of disseminated Acanthamoeba sp. infection with miltefosine.Successful treatment of a case of primary amoebic meningoencephalitis: How important is history taking.Black cobra (Naja naja karachiensis) lysates exhibit broad-spectrum antimicrobial activitiesIn vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B.Autopsy case of amebic granulomatous meningoencephalitis caused by Balamuthia mandrillaris in Japan.Non-contact lens related Acanthamoeba keratitis.Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.
P2860
Q28239164-ECBA81B6-1B5B-4331-912E-8851CA36B605Q28304841-72B917A6-19A6-4A7D-9885-98FB5FEB3337Q33249811-9D35FB5E-F698-40FB-BB72-789910943C06Q33696939-9178B5D7-53AD-451C-89BA-F8811AFB0F75Q34188284-2F6F30C2-616F-406C-8347-A8104D54C1DDQ34368425-3A0C4D4F-CFDE-4580-80E3-0F06B82BB0C7Q34563068-E4743CCC-DC18-4E8C-8CCC-E3FB9AD86B90Q34680916-5317500E-C412-4765-8BB8-261B644D7549Q35169050-A91A4F11-BE29-434E-A9F5-060AF9E5ABE4Q35275972-3E082727-4962-4B8D-AFB0-00BA66D39E8CQ36107786-568FF097-CB02-44BB-B51E-A4D8502F6AA6Q36274377-C9E42468-61C6-4352-A6C2-9C75E041DBA6Q37015171-5F089858-D529-47FA-95FA-4EBFD5941357Q37594879-0769E7D5-6F5F-4124-BDA9-7A0E8EBFEDD7Q38325869-5F4E3D4B-AB8F-4101-A885-99192E07060CQ38675542-32F273CF-915D-49D4-82D1-FF71F236D32CQ38708287-5F1649C1-D323-438E-9424-77DFE8F2F795Q38928269-4DEBF640-EC29-441D-8D68-9C94356C15FEQ38947534-A547D6F8-D227-49AF-88CA-3BAC32218B02Q39189550-A30DE3B2-C0BD-4DAA-8141-235713E53700Q39959102-38EE14B8-F897-420A-B7D7-0AE988E061ABQ40079302-4EF7E145-798E-44AD-B8DA-941C368AC646Q40101951-C97DCDE4-AF6A-42C2-ADDA-2C8E2E3B6279Q40112154-3917E90B-3BE5-4212-BDE8-8A3304FB996BQ40114944-D74848A1-7DDA-4E02-86A5-2E74CB87C2FDQ40379688-4DD8646B-FD55-4F12-AC91-322F6ED8EC3BQ40689050-72066BDD-005E-464B-8C7C-51CE19B2872FQ41467445-4B8B155D-9D20-4AA8-AF08-F80B7B5F7668Q41467455-9749D56A-916C-4AE4-8B2F-7DE794707857Q41482865-A80FBCA6-B96A-42AF-A536-CEB56AD6570BQ41670344-A2F2FA48-A27F-4109-AF8A-909CD6DFD8F0Q41863479-27F518D6-5CA0-44AF-ABA5-F2B0EB0290C2Q41920510-014A16CF-DFA0-4FD3-AEB6-76004FC9DEEEQ42089089-0FA66DB1-26C8-462E-80A0-FA20958011B3Q42131054-FE9D456E-17F9-4DAA-B031-70B61AC3A629Q42224262-49A6F493-8481-42E1-955A-0E6F652BA393Q42360821-7D3F1AC3-A123-4FD4-941A-9F071476B7B0Q44117800-0D303E51-450A-4E40-8DF5-69CA46177706Q47110864-5BFBFA89-EA56-4D4C-BF2F-4BA2895B4BC6Q51173609-5CB57891-D3FA-429D-AD0C-AEF4D52CC90F
P2860
Opportunistic amoebae: challenges in prophylaxis and treatment.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Opportunistic amoebae: challenges in prophylaxis and treatment.
@ast
Opportunistic amoebae: challenges in prophylaxis and treatment.
@en
type
label
Opportunistic amoebae: challenges in prophylaxis and treatment.
@ast
Opportunistic amoebae: challenges in prophylaxis and treatment.
@en
prefLabel
Opportunistic amoebae: challenges in prophylaxis and treatment.
@ast
Opportunistic amoebae: challenges in prophylaxis and treatment.
@en
P1476
Opportunistic amoebae: challenges in prophylaxis and treatment.
@en
P2093
Frederick L Schuster
Govinda S Visvesvara
P356
10.1016/J.DRUP.2004.01.002
P577
2004-02-01T00:00:00Z